Cargando…
Evolving BioAssay Ontology (BAO): modularization, integration and applications
The lack of established standards to describe and annotate biological assays and screening outcomes in the domain of drug and chemical probe discovery is a severe limitation to utilize public and proprietary drug screening data to their maximum potential. We have created the BioAssay Ontology (BAO)...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108877/ https://www.ncbi.nlm.nih.gov/pubmed/25093074 http://dx.doi.org/10.1186/2041-1480-5-S1-S5 |
_version_ | 1782327802493665280 |
---|---|
author | Abeyruwan, Saminda Vempati, Uma D Küçük-McGinty, Hande Visser, Ubbo Koleti, Amar Mir, Ahsan Sakurai, Kunie Chung, Caty Bittker, Joshua A Clemons, Paul A Brudz, Steve Siripala, Anosha Morales, Arturo J Romacker, Martin Twomey, David Bureeva, Svetlana Lemmon, Vance Schürer, Stephan C |
author_facet | Abeyruwan, Saminda Vempati, Uma D Küçük-McGinty, Hande Visser, Ubbo Koleti, Amar Mir, Ahsan Sakurai, Kunie Chung, Caty Bittker, Joshua A Clemons, Paul A Brudz, Steve Siripala, Anosha Morales, Arturo J Romacker, Martin Twomey, David Bureeva, Svetlana Lemmon, Vance Schürer, Stephan C |
author_sort | Abeyruwan, Saminda |
collection | PubMed |
description | The lack of established standards to describe and annotate biological assays and screening outcomes in the domain of drug and chemical probe discovery is a severe limitation to utilize public and proprietary drug screening data to their maximum potential. We have created the BioAssay Ontology (BAO) project (http://bioassayontology.org) to develop common reference metadata terms and definitions required for describing relevant information of low-and high-throughput drug and probe screening assays and results. The main objectives of BAO are to enable effective integration, aggregation, retrieval, and analyses of drug screening data. Since we first released BAO on the BioPortal in 2010 we have considerably expanded and enhanced BAO and we have applied the ontology in several internal and external collaborative projects, for example the BioAssay Research Database (BARD). We describe the evolution of BAO with a design that enables modeling complex assays including profile and panel assays such as those in the Library of Integrated Network-based Cellular Signatures (LINCS). One of the critical questions in evolving BAO is the following: how can we provide a way to efficiently reuse and share among various research projects specific parts of our ontologies without violating the integrity of the ontology and without creating redundancies. This paper provides a comprehensive answer to this question with a description of a methodology for ontology modularization using a layered architecture. Our modularization approach defines several distinct BAO components and separates internal from external modules and domain-level from structural components. This approach facilitates the generation/extraction of derived ontologies (or perspectives) that can suit particular use cases or software applications. We describe the evolution of BAO related to its formal structures, engineering approaches, and content to enable modeling of complex assays and integration with other ontologies and datasets. |
format | Online Article Text |
id | pubmed-4108877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41088772014-08-04 Evolving BioAssay Ontology (BAO): modularization, integration and applications Abeyruwan, Saminda Vempati, Uma D Küçük-McGinty, Hande Visser, Ubbo Koleti, Amar Mir, Ahsan Sakurai, Kunie Chung, Caty Bittker, Joshua A Clemons, Paul A Brudz, Steve Siripala, Anosha Morales, Arturo J Romacker, Martin Twomey, David Bureeva, Svetlana Lemmon, Vance Schürer, Stephan C J Biomed Semantics Proceedings The lack of established standards to describe and annotate biological assays and screening outcomes in the domain of drug and chemical probe discovery is a severe limitation to utilize public and proprietary drug screening data to their maximum potential. We have created the BioAssay Ontology (BAO) project (http://bioassayontology.org) to develop common reference metadata terms and definitions required for describing relevant information of low-and high-throughput drug and probe screening assays and results. The main objectives of BAO are to enable effective integration, aggregation, retrieval, and analyses of drug screening data. Since we first released BAO on the BioPortal in 2010 we have considerably expanded and enhanced BAO and we have applied the ontology in several internal and external collaborative projects, for example the BioAssay Research Database (BARD). We describe the evolution of BAO with a design that enables modeling complex assays including profile and panel assays such as those in the Library of Integrated Network-based Cellular Signatures (LINCS). One of the critical questions in evolving BAO is the following: how can we provide a way to efficiently reuse and share among various research projects specific parts of our ontologies without violating the integrity of the ontology and without creating redundancies. This paper provides a comprehensive answer to this question with a description of a methodology for ontology modularization using a layered architecture. Our modularization approach defines several distinct BAO components and separates internal from external modules and domain-level from structural components. This approach facilitates the generation/extraction of derived ontologies (or perspectives) that can suit particular use cases or software applications. We describe the evolution of BAO related to its formal structures, engineering approaches, and content to enable modeling of complex assays and integration with other ontologies and datasets. BioMed Central 2014-06-03 /pmc/articles/PMC4108877/ /pubmed/25093074 http://dx.doi.org/10.1186/2041-1480-5-S1-S5 Text en Copyright © 2014 Abeyruwan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Proceedings Abeyruwan, Saminda Vempati, Uma D Küçük-McGinty, Hande Visser, Ubbo Koleti, Amar Mir, Ahsan Sakurai, Kunie Chung, Caty Bittker, Joshua A Clemons, Paul A Brudz, Steve Siripala, Anosha Morales, Arturo J Romacker, Martin Twomey, David Bureeva, Svetlana Lemmon, Vance Schürer, Stephan C Evolving BioAssay Ontology (BAO): modularization, integration and applications |
title | Evolving BioAssay Ontology (BAO): modularization, integration and applications |
title_full | Evolving BioAssay Ontology (BAO): modularization, integration and applications |
title_fullStr | Evolving BioAssay Ontology (BAO): modularization, integration and applications |
title_full_unstemmed | Evolving BioAssay Ontology (BAO): modularization, integration and applications |
title_short | Evolving BioAssay Ontology (BAO): modularization, integration and applications |
title_sort | evolving bioassay ontology (bao): modularization, integration and applications |
topic | Proceedings |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108877/ https://www.ncbi.nlm.nih.gov/pubmed/25093074 http://dx.doi.org/10.1186/2041-1480-5-S1-S5 |
work_keys_str_mv | AT abeyruwansaminda evolvingbioassayontologybaomodularizationintegrationandapplications AT vempatiumad evolvingbioassayontologybaomodularizationintegrationandapplications AT kucukmcgintyhande evolvingbioassayontologybaomodularizationintegrationandapplications AT visserubbo evolvingbioassayontologybaomodularizationintegrationandapplications AT koletiamar evolvingbioassayontologybaomodularizationintegrationandapplications AT mirahsan evolvingbioassayontologybaomodularizationintegrationandapplications AT sakuraikunie evolvingbioassayontologybaomodularizationintegrationandapplications AT chungcaty evolvingbioassayontologybaomodularizationintegrationandapplications AT bittkerjoshuaa evolvingbioassayontologybaomodularizationintegrationandapplications AT clemonspaula evolvingbioassayontologybaomodularizationintegrationandapplications AT brudzsteve evolvingbioassayontologybaomodularizationintegrationandapplications AT siripalaanosha evolvingbioassayontologybaomodularizationintegrationandapplications AT moralesarturoj evolvingbioassayontologybaomodularizationintegrationandapplications AT romackermartin evolvingbioassayontologybaomodularizationintegrationandapplications AT twomeydavid evolvingbioassayontologybaomodularizationintegrationandapplications AT bureevasvetlana evolvingbioassayontologybaomodularizationintegrationandapplications AT lemmonvance evolvingbioassayontologybaomodularizationintegrationandapplications AT schurerstephanc evolvingbioassayontologybaomodularizationintegrationandapplications |